Fractyl Health Inc (NASDAQ: GUTS) is -5.34% lower on its value in year-to-date trading and has touched a low of $1.74 and a high of $14.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GUTS stock was last observed hovering at around $1.85 in the last trading session, with the day’s gains setting it 0.1%.
Currently trading at $1.95, the stock is -2.33% and -12.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.86 million and changing 5.41% at the moment leaves the stock -50.75% off its SMA200. GUTS registered a loss of -57.42% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $2.2508 and a 200-day simple moving average (SMA200) of $3.98805.
The stock witnessed a -22.62% gain in the last 1 month and extending the period to 3 months gives it a -17.37%, and is -11.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.94% over the week and 9.07% over the month.
Profit margin for the company is -71104.12%. Distance from 52-week low is 12.07% and -86.55% from its 52-week high. The company has generated returns on investments over the last 12 months (-63.67%).
with sales reaching $10k over the same period.The EPS is expected to grow by 96.33% this year, but quarterly earnings will post -16.67% year-over-year.
Fractyl Health Inc (GUTS) Top Institutional Holders
The shares outstanding are 48.09M, and float is at 20.64M with Short Float at 12.46%.
Fractyl Health Inc (GUTS) Insider Activity
The most recent transaction is an insider sale by Rajagopalan Harith, the company’s Chief Executive Officer. SEC filings show that Rajagopalan Harith sold 96,517 shares of the company’s common stock on Nov 11 ’24 at a price of $2.47 per share for a total of $0.24 million. Following the sale, the insider now owns 0.49 million shares.
Fractyl Health Inc disclosed in a document filed with the SEC on Nov 11 ’24 that Caplan Jay David (President, Chief Product Off.) sold a total of 64,197 shares of the company’s common stock. The trade occurred on Nov 11 ’24 and was made at $2.47 per share for $0.16 million. Following the transaction, the insider now directly holds 0.15 million shares of the GUTS stock.
Still, SEC filings show that on Sep 12 ’24, Caplan Jay David (President, Chief Product Off.) disposed off 65,000 shares at an average price of $2.90 for $0.19 million. The insider now directly holds 30,484 shares of Fractyl Health Inc (GUTS).
